- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Recurrent Ovarian Germ Cell Tumor in Netherlands
Total 502 results
-
Centre Leon BerardMinistry of Health, FranceCompletedPigmented Villonodular SynovitisFrance, Netherlands, Italy, Poland, United Kingdom
-
Azienda Ospedaliera di PerugiaNot yet recruitingAdvanced Melanoma | Early MelanomaItaly, Sweden, France, Germany, Netherlands, Poland, Spain
-
Leiden University Medical CenterRecruiting
-
The Netherlands Cancer InstituteDutch Cancer SocietyWithdrawnLung Cancer | Surgery | Circulating Tumor CellNetherlands
-
M.E. van LindeMassachusetts General HospitalUnknownGlioma | GlioblastomaNetherlands
-
Tilburg UniversityCompletedLow Grade Glioma of Brain | Anaplastic Glioma of BrainNetherlands
-
PfizerCompletedLocally Advanced or Metastatic NRAS Mutant MelanomaUnited States, Australia, Germany, Italy, Netherlands
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumor | Central Nervous System TumorUnited States, Canada, Australia, Switzerland, Netherlands, New Zealand
-
Gynaecologisch Oncologisch Centrum ZuidRadboud University Medical Center; Maastricht University Medical Center; Erasmus... and other collaboratorsRecruitingRecurrent Ovarian Cancer | Therapy-Associated Cancer | Signal Transduction Pathway DeregulationNetherlands
-
University of BirminghamRoche Pharma AG; Cancer Research UK; Imagine for Margo; EUSA Pharma, Inc.Active, not recruitingNeuroblastomaFrance, Austria, Belgium, Denmark, Ireland, Italy, Spain, Switzerland, United Kingdom, Netherlands
-
University Medical Center GroningenCompleted
-
Boehringer IngelheimRecruitingMelanoma | Non-small Cell Lung Cancer (NSCLC) | Carcinoma, Squamous Cell of Head and Neck (HNSCC)Netherlands
-
AstraZenecaRTI Health Solutions; A+A Healthcare Marketing Research; Freelance CRA (FCRA)CompletedPlatinum-sensitive Recurrent Serous Ovarian CancerFrance, Italy, Korea, Republic of, Spain, United Kingdom, Germany, Belgium, Israel, Portugal, Netherlands, Switzerland, Canada, Australia
-
Amsterdam UMC, location VUmcNot yet recruitingGlioma | Cognitive ImpairmentNetherlands
-
Paul G. Kemps, MDJuliana Children's HospitalActive, not recruitingHepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Burkitt Lymphoma | Neuroendocrine Tumors | Gastrointestinal Cancer | HepatoblastomaNetherlands
-
Gustave Roussy, Cancer Campus, Grand ParisNational Cancer Institute, FranceTerminatedVery High Risk NeuroblastomaItaly, Austria, France, Netherlands, Spain
-
Novartis PharmaceuticalsCompletedCarcinoma | Neuroendocrine | Advanced and Metastatic Silent Neuro-Endocrine Tumors | Non Functioning Neuroendocrine Tumors (NETs) | Non Syndromic Neuroendocrine Tumors | Carcinoids | Non FunctioningSweden, Italy, Germany, United Kingdom, Spain, France, Netherlands, Poland
-
Radboud University Medical CenterUMC Utrecht; ZonMw: The Netherlands Organisation for Health Research and Development and other collaboratorsActive, not recruitingPrimary GlioblastomaNetherlands
-
Daiichi Sankyo, Inc.OptimapharmCompletedGiant Cell TumorsUnited States, France, Spain, Netherlands, Italy, Austria, United Kingdom, Germany
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsBelgium, Spain, Germany, Netherlands, Finland
-
AmgenCompletedCancer | Giant Cell Tumor of Bone | Giant Cell Tumors | Benign Giant Cell TumorsUnited States, Canada, Sweden, Poland, Germany, Netherlands, Australia, Italy, Austria, Spain, France, United Kingdom
-
Immatics Biotechnologies GmbHBioNTech SE; University Hospital Tuebingen; BCN Peptides; EU-funded GAPVAC ConsortiumCompletedGlioblastomaSpain, Switzerland, Denmark, Germany, Netherlands
-
Aprea TherapeuticsCompletedPlatinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53United States, France, Spain, Netherlands, United Kingdom, Belgium, Germany, Sweden
-
StemgenORION Clinical ServicesCompletedGlioblastomaNetherlands, Israel, Italy
-
Day One Biopharmaceuticals, Inc.Pacific Pediatric Neuro-Oncology ConsortiumRecruitingAdvanced Solid Tumor | Low-grade GliomaUnited States, Israel, Korea, Republic of, Denmark, Singapore, Netherlands, Canada, Australia, Germany, Switzerland, United Kingdom
-
Radboud University Medical CenterThe Netherlands Cancer Institute; IsalaRecruitingMelanoma, Malignant, of Soft PartsNetherlands
-
Bristol-Myers SquibbCompletedMelanomaItaly, Netherlands, Russian Federation, Czechia, Hungary, Ireland, Norway, Spain, Switzerland, Austria, Germany, Denmark, France, Belgium, United Kingdom, United States
-
European Organisation for Research and Treatment...Active, not recruitingCutaneous MelanomaFrance, Italy, Switzerland, Belgium, Netherlands, Germany, Poland, Slovenia, United Kingdom, Spain
-
Princess Maxima Center for Pediatric OncologyInnovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids CancerNot yet recruitingAcute Lymphoblastic Leukemia, in Relapse | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) RefractoryNetherlands
-
Princess Maxima Center for Pediatric OncologyInnovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids CancerNot yet recruitingAcute Lymphoblastic Leukemia, in Relapse | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) RefractoryNetherlands
-
Princess Maxima Center for Pediatric OncologyInnovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids CancerWithdrawnAcute Lymphoblastic Leukemia, in Relapse | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) RefractoryNetherlands
-
Novartis PharmaceuticalsCompletedUveal MelanomaUnited Kingdom, France, Netherlands, United States
-
European Organisation for Research and Treatment...CompletedBrain and Central Nervous System TumorsSwitzerland, Italy, Belgium, Germany, Netherlands
-
Novartis PharmaceuticalsRecruitingGlioblastoma Multiforme | Gastroesophageal Adenocarcinoma | Pancreatic Ductal AdenocarcinomaNetherlands, Spain, Israel, United States, Switzerland
-
Princess Maxima Center for Pediatric OncologyInnovative Therapies For Children with Cancer Consortium; IBFM; Fight Kids CancerNot yet recruitingAcute Lymphoblastic Leukemia | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic...Netherlands
-
Bristol-Myers SquibbEuropean Organisation for Research and Treatment of Cancer - EORTCTerminatedGlioblastomaSwitzerland, Netherlands, Italy, France
-
Marnix LamCompletedNeuroendocrine Tumors | Liver MetastasesNetherlands
-
AbbVie (prior sponsor, Abbott)CompletedPrimary Peritoneal Cancer | Fallopian Tube | Solid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and OvarianNetherlands
-
PfizerPierre Fabre LaboratoriesActive, not recruitingAdvanced Solid Tumors | Metastatic MelanomaUnited States, Spain, Belgium, Canada, Netherlands
-
Leiden University Medical CenterErasmus Medical Center; Amsterdam UMC, location VUmc; Medical Center HaaglandenRecruiting
-
Five Prime Therapeutics, Inc.CompletedTenosynovial Giant Cell Tumor | Pigmented Villonodular SynovitisUnited States, France, Netherlands, United Kingdom, Korea, Republic of, Poland
-
IpsenCompletedMidgut Neuroendocrine Tumours | Pancreatic TumoursSpain, United Kingdom, Denmark, Belgium, Germany, France, Netherlands, Ireland, Italy, Poland
-
Maastricht University Medical CenterActive, not recruitingRecurrence | Surgery | Metastasis | Squamous Cell Carcinoma | Lip | Surgical Margin | Lip Cancer | Lip SCC | Squamous Cell Carcinoma of the Lip | Tumor Free MarginsNetherlands
-
Maastricht Radiation OncologyWithdrawnGlioblastoma Multiforme | Anaplastic Oligoastrocytoma | Anaplastic AstrocytomaNetherlands
-
Daiichi Sankyo, Inc.CompletedTenosynovial Giant Cell TumorUnited States, Spain, Taiwan, Australia, Hungary, Italy, Netherlands
-
ITM Solucin GmbHABX CRO; PSI CROActive, not recruitingNeuroendocrine TumorsGermany, France, United States, United Kingdom, Australia, Italy, Belgium, Switzerland, Czechia, Spain, Austria, Netherlands, Poland, South Africa
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
Deciphera Pharmaceuticals LLCActive, not recruitingTenosynovial Giant Cell Tumor | Giant Cell Tumor of Tendon Sheath | Pigmented Villonodular Synovitis | Tenosynovial Giant Cell Tumor, Diffuse | Tenosynovial Giant Cell Tumor, LocalizedNorway, United States, France, Spain, Hong Kong, Netherlands, Italy, Germany, Australia, United Kingdom, Canada, Poland, Switzerland
-
Erasmus Medical CenterAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Leiden University... and other collaboratorsRecruitingOligodendroglioma | Astrocytoma, Grade III | Astrocytoma, Grade II | Oligodendroglioma, AnaplasticNetherlands
-
Novartis PharmaceuticalsCompletedPancreatic Neoplasms | Neuroendocrine Tumor | Neuroendocrine Carcinoma | Islet Cell CarcinomaUnited States, Canada, Spain, Argentina, Germany, Belgium, Italy, France, Sweden, Australia, Netherlands